CLINICAL_TRIALS
withdrawal
· 2015-09-22
Clinical Trial Update: The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements [Phase 1, Phase 2]
Summary
Clinical trial evaluating RPh201 in patients with chronic vegetative state (Phase 1 and Phase 2) has been withdrawn. The sponsor listed is Hadassah Medical Orga…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hadassah Medical Organization | Conditions: Chronic Vegetative State | Phase 1, Phase 2 | Status: WITHDRAWN